LinkDRTB

Project Overview

Pragmatic innovative approaches to Health system strengthening, Quality improvement programs, surveillance to improve MDR-TB case detection, HIV-co-infected clients for HAART as well as to prevent loss-to-follow-up clients and reduce morbidity and mortality. Encourage continuous dialogue with our communities through robust engagements through information sessions and capacity building on TB/HIV&AIDS, Employee wellness programs, Programmatic Management of Drug Resistant Tuberculosis (PMDT) Programs to raise awareness and understanding of MDR-TB disease, its manifestations, referral structure, and management.

Geographic Coverage

Through effective partnership, Amity Health Consortium Projects works country wide providing support in all our communities with focus on key populations, the four DR-TB high burden provinces that contributes more than 70% of the disease burden in South Africa.

Focus Areas

Quality improvement programs using pragmatic innovative approaches, TB/HIV& AIDS technical services, Occupation Health, Employee wellness and Safety services. Improving the Quality of Programmatic Management of Drug Resistant Tuberculosis (PMDT) Services. Building effective partnerships with Department of Health, National TB Control Programme (DR-TB Cluster), all our communities in various districts and provinces in South Africa to ensure health system strengthening, capacity building, clinical mentorship and support supervision, quality improvement programs, improve universal access to and quality of care among DR-TB clients. Effectively utilize innovative health solutions (m-Health) to ensure linkage and retention in care for all our DR-TB clients. Conducting operational research and documentaries in all our projects jointly with institutional partners.

Increasing the Availability of TB/HIV&AIDS Services

Providing context-specific MDR-TB capacity building on programmatic and clinical management, clinical mentorship with support supervision to health care workers.

General Information

The International Association of Providers of AIDS Care (IAPAC) is pleased to announce the 6th International Conference on Viral Hepatitis (ICVH 2016), which will take place March 14-15, 2016, at the Mission Bay Conference Center in San Francisco.

ICVH 2016 is sponsored by IAPAC, in partnership with the University of California, San Francisco and the International Association for the Study of the Liver (IASL). The conference Co-Chairs are Vicente Soriano, MD, PhD (Hospital Carlos III, Madrid, SPAIN) and Norah Terrault, MD, MPH (University of California, San Francisco, CA, USA).

The annual conference is a forum for the presentation and discussion of state-of-the-science viral hepatitis research, as well as clinical perspectives in practicum, for a target audience made up of infectious disease (ID) and non-ID-specialized HIV-treating physicians, nurse-practitioners, physician-assistants, and pharmacists.

Nancy S. Reau, MD (University of Chicago, IL, USA) is confirmed to present the conference's Keynote Address, ‘After the Cure: Looking Ahead in HCV Clinical Management.‘

The University of California, San Francisco, designates this live activity for a maximum of 10.5 AMA PRA Category 1 Credit TM. Continuing education applications for nursing and pharmacy credits are pending. Online registration is now open. More info

Conference Announcement

Adherence 2016 (11th International Conference on HIV Treatment and Prevention Adherence) will take place May 9-11, 2016, in Fort Lauderdale, FL, USA. Hosted by the International Association of Providers of AIDS Care (IAPAC), Adherence 2016 will be co-chaired by K. Rivet Amico, PhD (University of Michigan, Ann Arbor, MI, USA) and Michael J. Mugavero, MD, MHSc (University of Alabama at Birmingham, AL, USA).

Adherence 2016 is the premier conference dedicated to the presentation and discussion of HIV treatment and biomedical prevention adherence research, as well as current behavioral and clinical perspectives in practicum, within the context of achieving an optimized continuum of HIV care and prevention.

Adherence 2016 will take place at a critical time in the fight against HIV/AIDS, as the global HIV community coalesces around ambitious 90-90-90 targets and aims to scale up access to biomedical prevention, including postexposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP). Key to attaining the 90-90-90 targets and facilitiating the scale-up of biomedical prevention interventions is the optimization of HIV care and prevention continua and mitigation of barriers such as discrimination and stigma, including in healthcare settings.

The online abstract submission site will open December 4, 2015. Take advantage of an Early Bird Registration offer through December 18, 2015.The Early Bird Registration rates are $249 for IAPAC members; $349 for non-IAPAC members; and $149 for students*/retired individuals - a $50 savings off of Early Registration rates. More info

General Information

Offline registration closes today, 11 November. Any registration forms received after midnight CET will not be processed. Delegates wishing to pay by bank transfer will need to register offline. Send your registration form to registration@theunion.org along with a copy of your bank transfer order before the end of the day. Any payments made via bank transfer after that deadline may not be received in time, and the registration not processed prior to the conference. Online registration will be available until 30 November and delegates will also be able to register on site. On-site registrations are payable in cash, travellers cheque, or by credit card.

Imbizo: a conference within the conference

Imbizo is a vibrant space where communities involved in the fight for lung health will come together for discussion, support, learning and inspiration. Imbizo – meaning a gathering, usually called by a traditional leader – will host a range of sessions, displays, discussions and performances from community organisations and civil society. Imbizo will be open from Wednesday, 2 December through Sunday, 6 December in Hall 4B. This area is open to both delegates and non-delegates. Find out more about Imbizo. More info

General Information